{"transactions":[{"id":803360,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51708,"kind":"person","name":"Donohue James J.","position":1,"cik":"0001869107","reported_name":"Donohue James J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-04-22T16:20:10.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":2150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. The shares subject to the options shall vest on April 20, 2027."}],"balance_after":2150,"derivative":{"exercise_price":2.36,"exercise_date":"2027-04-20","expiration_date":"2036-04-20","underlying":"Common Stock","underlying_shares":2150},"source":{"system":"sec-edgar","filing":"0001104659-26-046842","document":"tm2612397-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869107/000110465926046842/tm2612397-6_4seq1.xml","form_type":"4"}},{"id":1307213,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51708,"kind":"person","name":"Donohue James J.","position":1,"cik":"0001869107","reported_name":"Donohue James J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants for Common Stock","published_at":"2025-01-08T16:31:05.000Z","date":"2025-01-06","kind":"purchase","planned":false,"acquired":true,"shares":9852,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Acquired in a concurrent private placement of warrants by Acurx Pharmaceuticals, Inc. in connection with the registered direct offering of common stock."}],"balance_after":9852,"derivative":{"exercise_price":0.9,"exercise_date":"2025-01-07","expiration_date":"2030-01-07","underlying":"Common Stock","underlying_shares":9852},"source":{"system":"sec-edgar","filing":"0001104659-25-002051","document":"tm252665-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869107/000110465925002051/tm252665-3_4seq1.xml","form_type":"4"}},{"id":1307212,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51708,"kind":"person","name":"Donohue James J.","position":1,"cik":"0001869107","reported_name":"Donohue James J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-08T16:31:05.000Z","date":"2025-01-06","kind":"purchase","planned":false,"acquired":true,"shares":9852,"price":1.015,"value":9999.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired at the offering price in a registered direct offering of common stock by Acurx Pharmaceuticals, Inc."}],"balance_after":22352,"source":{"system":"sec-edgar","filing":"0001104659-25-002051","document":"tm252665-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869107/000110465925002051/tm252665-3_4seq1.xml","form_type":"4"}},{"id":1476333,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51708,"kind":"person","name":"Donohue James J.","position":1,"cik":"0001869107","reported_name":"Donohue James J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-06-18T16:11:34.000Z","date":"2024-06-17","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. The shares subject to the options shall vest on June 17, 2025."}],"balance_after":12000,"derivative":{"exercise_price":2.38,"expiration_date":"2034-06-17","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001104659-24-072808","document":"tm2417510-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869107/000110465924072808/tm2417510-2_4seq1.xml","form_type":"4"}},{"id":1853370,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51708,"kind":"person","name":"Donohue James J.","position":1,"cik":"0001869107","reported_name":"Donohue James J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-06-16T17:46:42.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. The shares subject to the options shall vest on June 15, 2024."}],"balance_after":10000,"derivative":{"exercise_price":2.75,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-23-072372","document":"tm2319012-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869107/000110465923072372/tm2319012-5_4seq1.xml","form_type":"4"}},{"id":2642531,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51708,"kind":"person","name":"Donohue James J.","position":1,"cik":"0001869107","reported_name":"Donohue James J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-07-06T16:12:00.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. 1/36th of the shares granted shall become vested and exercisable as of each monthly anniversary from July 1, 2021, such that all shares subject to this stock option shall be fully vested and exercisable by July 1, 2024."}],"balance_after":50000,"derivative":{"exercise_price":6.18,"expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-21-089408","document":"tm2121302d2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869107/000110465921089408/tm2121302d2_4seq1.xml","form_type":"4"}}]}